Sabra Healthcare REIT Inc

$ 20.68

0.10%

17 Apr - close price

  • Market Cap 5,214,373,000 USD
  • Current Price $ 20.68
  • High / Low $ 20.76 / 20.50
  • Stock P/E 32.31
  • Book Value 11.21
  • EPS 0.64
  • Next Earning Report 2026-04-29
  • Dividend Per Share $1.20
  • Dividend Yield 5.81 %
  • Next Dividend Date -
  • ROA 0.03 %
  • ROE 0.06 %
  • 52 Week High 21.07
  • 52 Week Low 15.97

About

As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 skilled nursing / transitional care facilities, (ii) 64 senior housing communities (?

Analyst Target Price

$22.00

Quarterly Earnings

Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Reported Date 2026-02-122025-10-292025-08-042025-05-062025-02-252024-10-312024-08-072024-05-082024-02-272023-11-062023-08-072023-05-03
Reported EPS 0.110.16640.270.1670.16920.130.10.110.07-0.070.09-0.04
Estimated EPS 0.170.1820.180.140.170.160.150.140.130.130.10.11
Surprise -0.06-0.01560.090.027-0.0008-0.03-0.05-0.03-0.06-0.2-0.01-0.15
Surprise Percentage -35.2941%-8.5714%50%19.2857%-0.4706%-18.75%-33.3333%-21.4286%-46.1538%-153.8462%-10%-136.3636%

Next Quarterly Earnings

Mar 2026
Reported Date 2026-04-29
Fiscal Date Ending 2026-03-31
Estimated EPS 0.38
Currency USD

Previous Dividend Records

Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024Aug 2024May 2024Feb 2024Nov 2023
Payment Date 2026-02-272025-11-282025-08-292025-05-302025-02-282024-11-292024-08-302024-05-312024-02-292023-11-30
Amount $0.3$0.3$0.3$0.3$0.3$0.3$0.3$0.3$0.3$0.3

Next Dividend Records

Dividend per share (year): -
Dividend Yield -
Next Dividend Date -
Ex-Dividend Date -

Recent News: SBRA

...
Sumitomo Mitsui Trust Group Inc. Raises Stock Holdings in Sabra Healthcare REIT, Inc. $SBRA

2026-04-16 09:21:44

Sumitomo Mitsui Trust Group Inc. significantly increased its stake in Sabra Healthcare REIT, Inc. by 1,019.8% in Q4, acquiring over 2.7 million shares and holding approximately 1.21% of the company. This comes despite Sabra missing quarterly EPS expectations, though revenue increased year-over-year. The REIT offers a 5.9% dividend yield and has a "Moderate Buy" consensus rating from analysts with an average price target of $22.00.

...
Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price Passes Above Two Hundred Day Moving Average - Here's Why

2026-04-16 06:38:44

Sabra Healthcare REIT (NASDAQ:SBRA) recently saw its stock price climb above its 200-day moving average, reaching $20.49 with strong trading volume. Several analysts have raised their price targets for SBRA, contributing to a "Moderate Buy" consensus rating with a target of $22.00. Despite missing quarterly EPS estimates, the company reported 16.2% year-over-year revenue growth and offers a 5.9% dividend yield.

Sabra Health Care REIT sets April 30 call on first-quarter results

2026-04-15 20:10:15

Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced that it will release its first-quarter 2026 earnings on April 29, 2026, after the close of trading. The company will also host a conference call and webcast to discuss these results on April 30th at 10:00 a.m. Pacific Time. Sabra is a real estate investment trust specializing in healthcare properties across the United States and Canada.

...
Sabra Health Care REIT Announces Q1 2026 Earnings Release

2026-04-15 09:59:00

Sabra Health Care REIT, focused on healthcare properties, will release its Q1 2026 financial results on April 29, 2026, and host a conference call the same day. This report is crucial for understanding the current state and outlook of the healthcare real estate market, including senior housing and skilled nursing facilities. Investors will be looking for signs of recovery or challenges in the sector.

...
Sabra Health Care REIT, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics

2026-04-11 23:09:02

Sabra Health Care REIT, Inc. recently underwent a stock evaluation revision due to changing market conditions. The company's stock currently stands at $20.24, with a year-to-date return of 6.86% and a three-year return of 89.34%, outperforming the S&P 500 over that extended period. Technical indicators show mixed signals, with bullish signs in weekly MACD and KST but a bearish monthly RSI.

SBRA Financials: Revenue Breakdown, Margins & Competitor Comparison

2026-04-08 18:39:42

This article provides a financial overview of Sabra Health Care REIT Inc (SBRA), detailing its profitability margins and comparing it to competitors. SBRA maintains a gross margin of 63.75%, an operating margin of 30.48%, and a net margin of 12.81%, with a Return on Equity (ROE) of 5.59%. The company, with a market capitalization of $5.06 billion, is benchmarked against industry leaders like PECO and MAC, highlighting its competitive position regarding efficiency.

Iscriviti alla nostra newsletter

Email Subscription Form


Resta aggiornato. Ricevi tutti i nuovi articoli e le notizie ogni settimana.
banner startinvesting

Questo si chiuderà in 0 secondi